Genome-wide association study implicates NDST3 in schizophrenia and bipolar disorder

Nature Communications

Volumn 4, Issue , 2013, Pages

  Lencz, Todd ^a,b,c,d   Guha, Saurav ^a   Liu, Chunyu ^e   Rosenfeld, Jeffrey ^a   Mukherjee, Semanti ^a   DeRosse, Pamela ^a   John, Majnu ^a   Cheng, Lijun ^f   Zhang, Chunling ^f   Badner, Judith A ^f   Ikeda, Masashi ^g   Iwata, Nakao ^g   Cichon, Sven ^h   Rietschel, Marcella ⁱ   Nöthen, Markus M ^h   Cheng, A T A ^j   Hodgkinson, Colin ^k   Yuan, Qiaoping ^k   Kane, John M ^a,b,c,d   Lee, Annette T ^b   Pisanté, Anne ^l   Gregersen, Peter K ^b,d   Pe'er, Itsik ^m   Malhotra, Anil K ^a,b,c,d   Goldman, David ^k   Darvasi, Ariel ^l   more..

^a ZUCKER HILLSIDE HOSPITAL   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^f UNIVERSITY OF CHICAGO   (United States)

^g FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h UNIVERSITY OF BONN   (Germany)

ⁱ UNIVERSITY OF MANNHEIM   (Germany)

^j INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^k NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^l HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^m Hebrew University of Jerusalem ^*  (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEPARAN SULFATE; NDST3 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

CHROMOSOME; GENE EXPRESSION; GENETIC VARIATION; GENOME; METABOLISM; POLYMORPHISM; SAMPLING;

ARTICLE; BIPOLAR DISORDER; CHROMOSOME 4Q; CONTROLLED STUDY; ETHNICITY; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

BIPOLAR DISORDER; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; JEWS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; SULFOTRANSFERASES;

EID: 84893361550     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms3739     Document Type: Article

References (48)

1. Perälä, J. et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch. Gen. Psychiatry 64, 19-28 (2007).
2. Prince, M. et al. No health without mental health. Lancet 370, 859-877 (2007).
3. Laursen, T. M. et al. Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia. J. Clin. Psychiatry 68, 899-907 (2007).
4. Cardno, A. G. et al. Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch. Gen. Psychiatry 56, 162-168 (1999).
5. Williams, H. J. et al. Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date cross-traditional diagnostic boundaries. Hum. Mol. Genet. 20, 387-391 (2011).
6. The International Schizophrenia Consortium. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748-752 (2009).
7. Cross-Disorder Group of the Psychiatric Genomics Consortium. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat. Genet. 45, 984-994 (2013).
8. Van Snellenberg, J. X. & de Candia, T. Meta-analytic evidence for familial coaggregation of schizophrenia and bipolar disorder. Arch. Gen. Psychiatry 66, 748-755 (2009).
9. Lee, S. H. et al. Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs. Nat. Genet. 44, 247-250 (2012).
10. The Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium. Genome-wide association study identifies five novel schizophrenia loci. Nat. Genet. 43, 969-976 (2011).
11. Psychiatric GWAS Consortium Bipolar Disorder Working Group. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat. Genet. 43, 977-983 (2011).
12. Kristiansson, K., Naukkarinen, J. & Peltonen, L. Isolated populations and complex disease gene identification. Genome Biol. 9, 109 (2008).
13. Price, A. L., Zaitlen, N. A., Reich, D. & Patterson, N. New approaches to population stratification in genome-wide association studies. Nat. Rev. Genet. 11, 459-463 (2010).
14. Gibson, G. Rare and common variants: twenty arguments. Nat. Rev. Genet. 13, 135-145 (2012).
15. Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190-2191 (2010).
16. Galante, P. A., Sakabe, N. J., Kirschbaum-Slager, N. & de Souza, S. J. Detection and evaluation of intron retention events in the human transcriptome. RNA 10, 757-765 (2004).
17. Aikawa, J. & Esko, J. D. Molecular cloning and expression of a third member of the heparan sulfate/heparin GlcNAc N-deacetylase/N-sulfotransferase family. J. Biol. Chem. 274, 2690-2695 (1999).
18. Lein, E. S. et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature 445, 168-176 (2007).
19. Pallerla, S. R. et al. Altered heparan sulfate structure in mice with deleted NDST3 gene function. J. Biol. Chem. 283, 16885-16894 (2008).
20. Lander, A. D. & Selleck, S. B. The elusive functions of proteoglycans: in vivo veritas. J. Cell Biol. 148, 227-232 (2000).
21. Irie, F. et al. Heparan sulfate regulates ephrin-A3/EphA receptor signaling. Proc. Natl Acad. Sci. USA 105, 12307-12312 (2008).
22. Inatani, M., Irie, F., Plump, A. S., Tessier-Lavigne, M. & Yamaguchi, Y. Mammalian brain morphogenesis and midline axon guidance require heparan sulfate. Science 302, 1044-1046 (2003).
23. Lucido, A. L. et al. Rapid assembly of functional presynaptic boutons triggered by adhesive contacts. J. Neurosci. 29, 12449-12466 (2009).
24. Pankonin, M. S., Gallagher, J. T. & Loeb, J. A. Specific structural features of heparan sulfate proteoglycans potentiate neuregulin-1 signaling. J. Biol. Chem. 280, 383-388 (2005).
25. Green, E. K. et al. Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder. Arch. Gen. Psychiatry. 62, 642-648 (2005).
26. Shi, Y. et al. Common variants on 8p12 and 1q24.2 confer risk of schizophrenia. Nat. Genet. 43, 1224-1227 (2011).
27. Yue, W. Genome-wide association study identifies a susceptibility locus for schizophrenia in Han Chinese at 11p11.2. Nat. Genet. 43, 1228-1231 (2011).
28. Zhong, H. & Prentice, R. L. Bias-reduced estimators and confidence intervals for odds ratios in genome-wide association studies. Biostatistics 9, 621-634 (2008).
29. Kirchhoff, T. et al. The 6q22.33 locus and breast cancer susceptibility. Cancer. Epidemiol. Biomarkers. Prev. 18, 2468-2475 (2009).
30. Peter, I. et al. Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control study. BMC Med. Genet. 6, 63 (2011).
31. Behar, D. M. et al. The matrilineal ancestry of Ashkenazi Jewry: portrait of a recent founder event. Am. J. Hum. Genet. 78, 487-497 (2006).
32. Palamara, P. F., Lencz, T., Darvasi, A. & Pe'er, I. Length distributions of identity by descent reveal fine-scale demographic history. Am. J. Hum. Genet. 91, 809-822 (2012).
33. Teo, Y. Y. et al. Power consequences of linkage disequilibrium variation between populations. Genet. Epidemiol. 33, 128-135 (2009).
34. Gusev, A. et al. The architecture of long-range haplotypes shared within and across populations. Mol. Biol. Evol. 29, 473-486 (2011).
35. Guha, S. et al. Implications for health and disease in the genetic signature of the Ashkenazi Jewish population. Genome. Biol. 13, R2 (2012).
36. Laaksovirta, H. et al. Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study. Lancet. Neurol. 9, 978-985 (2010).
37. Jakkula, E. et al. Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. Am. J. Hum. Genet. 86, 285-291 (2010).
38. First, M. B., Spitzer, R. L., Gibbon, M. & Williams, J. B. W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P) (Biometrics Research, New York State Psychiatric Institute, 1994).
39. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559-575 (2007).
40. Nyholt, D. R. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am. J. Hum. Genet. 74, 765-769 (2004).
41. Kang, H. M. et al. Variance component model to account for sample structure in genome-wide association studies. Nat. Genet. 42, 348-354 (2010).
42. Howie, B. N., Fuchsberger, C., Stephens, M., Marchini, J. & Abecasis, G. R. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat. Genet. 44, 955-959 (2012).
43. Howie, B. N., Donnelly, P. & Marchini, J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 5, e1000529 (2009).
44. The CARDIoGRAMplusC4D Consortium. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat. Genet. 45, 25-33 (2013).
45. Nyholt, D. R. et al. Genome-wide association meta-analysis identifies new endometriosis risk loci. Nat. Genet. 44, 1355-1359 (2012).
46. Zhang, D. et al. Genetic control of individual differences in gene-specific methylation in human brain. Am. J. Hum. Genet. 86, 411-419 (2010).
47. Johnson, W. E., Li, C. & Rabinovic, A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8, 118-127 (2007).
48. Leek, J. T. & Storey, J. D. Capturing heterogeneity in gene expression studies by surrogate variable analysis. PLoS Genet. 3, 1724-1735 (2007).